نتایج جستجو برای: febrile neutropenia drug

تعداد نتایج: 606432  

Journal: :Indian Journal of Pharmaceutical Sciences 2023

Febrile neutropenia is a common and serious complication of cancer chemotherapy. This pathology characterized by diminished absolute neutrophil count elevated temperature. Despite recent therapeutic advances, febrile still major cause morbidity mortality among patients in Latin America worldwide. onco-hematological emergency condition also involves high risk complications healthcare costs. The ...

Journal: :Advances in lung cancer 2021

Lymphomas are neoplastic transformations that affect lymphoid cells. Diffuse large B-cell non-Hodgkin’s lymphoma has a high degree of cell proliferation, accounting for 30% all lymphomas. Lung cancer is the leading cause death worldwide and recommended treatment chemotherapy. Among main complications resulting from lymphoma, lung chemotherapy used in their treatment, we can mention sepsis, acut...

Journal: :Journal of Hematology and Allied Sciences 2022

Azathioprine is an immunomodulator commonly used in renal transplant recipients and to treat lupus erythematous, inflammatory bowel disease, as second-line therapy cases of rheumatoid arthritis. Here, we present a case non-segmental vitiligo treated with low-dose azathioprine developing life-threatening pancytopenia febrile neutropenia trephine biopsy-proven drug-induced myelosuppression. The p...

Journal: :Archives of Disease in Childhood 2007

Journal: :Journal of Evolution of Medical and Dental Sciences 2014

Journal: :Biology of Blood and Marrow Transplantation 2019

Journal: :Medical Science and Discovery 2023

Objective: Candidiasis" is the predominant fungal infection that occurs invasively and opportunistically in individuals with compromised immune systems. Febrile neutropenia patients receiving cytotoxic chemotherapy due to malignancy, especially acute leukemia stem cell transplantation are at greater risk among many others. In this study, it was aimed search for Candida DNA make an early diagnos...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
David A Rizzieri Valerie K Ibom Joseph O Moore Carlos M DeCastro Gary L Rosner David J Adams Traci Foster Nancy Payne Maria Thompson James J Vredenburgh Christina Gasparetto Gwynn D Long Nelson J Chao Jon P Gockerman

PURPOSE The purpose of this study was to determine the maximum tolerated duration of infusion of gemcitabine at 10 mg/m(2)/min in combination with fludarabine at 25 mg/m(2) daily for 5 days in the treatment of relapsed or refractory acute myelogenous leukemia. EXPERIMENTAL DESIGN Eighteen patients with relapsed or refractory acute myelogenous leukemia were enrolled. The median age was 54.5 ye...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید